Film & TVFree Chernobyl, the HBO miniseries: Fact and fiction May 17, 2019Vol.45 No.20By Robert Peter Gale
Conversation with The Cancer LetterFree Libutti: How Rutgers Cancer Institute became a New Jersey-sized colossus May 17, 2019Vol.45 No.20By Paul Goldberg
FreeTrials & Tribulations Estimating overdiagnosis is hard—we need all the help we can get May 10, 2019Vol.45 No.19By Ruth Etzioni and Roman Gulati
FreeTrials & Tribulations A comparison of study designs for estimating overdiagnosis in cancer screening May 03, 2019Vol.45 No.18By Barry Kramer and Philip C. Prorok
Drugs & TargetsFree FDA approves Balversa for urothelial carcinoma with FGFR genetic alterations April 19, 2019Vol.45 No.16
Drugs & TargetsFree FDA expands pembrolizumab indication for first-line treatment of NSCLC April 19, 2019Vol.45 No.16
Drugs & TargetsFree Aprea Therapeutics receives FDA Fast Track and Orphan Drug designations for APR-246 for MDS April 19, 2019Vol.45 No.16
Drugs & TargetsFree Intensity Therapeutics receives Fast Track designation for development of INT230-6 in breast cancer April 19, 2019Vol.45 No.16
Drugs & TargetsFree Stanford partners with Notable and Tempus to make rapid personalized treatment in blood cancer patients April 19, 2019Vol.45 No.16
